CompletedPhase 3

Alveolar Ridge Preservation Using Different Bone Substitutes

Egypt30 participantsStarted 2017-06-20

Plain-language summary

The primary objective of this study was to compare the efficacy of using allograft, autogenous tooth graft, and beta-tricalcium phosphate for alveolar ridge preservation (ARP) by examining the alveolar ridge height and width at baseline and 3 months after the ARP both clinically and radiographically. The secondary objective was to evaluate the quality of the newly formed bone using histomorphometric analysis.

Who can participate

Age range20 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. seeking implant-based restorations after tooth extraction.
✓. exhibited no evidence of any significant medical history, measured using Burket's Oral medicine health history questionnaire.
✓. exhibited Type I and II sockets

Exclusion criteria

✕. nonsmokers.
✕. Pregnant and breast-feeding females
✕. patients with known contraindications to dental implant surgery (e.g., increased bleeding tendency, history of treatments such as radiotherapy,

What they're measuring

Clinical assessment

Timeframe: 3 months

Clinical assessment

Timeframe: 3 months

Trial details

NCT IDNCT05812872

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09-23

View on ClinicalTrials.gov More Alveolar Ridge Enlargement trials